Chemours
462 hedge funds and large institutions have $5.42B invested in Chemours in 2017 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 139 increasing their positions, 147 reducing their positions, and 61 closing their positions.
23% more call options, than puts
Call options by funds: $79.4M | Put options by funds: $64.6M
15% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 61
1% more funds holding
Funds holding: 458 → 462 (+4)
3% less capital invested
Capital invested by funds: $5.6B → $5.42B (-$173M)
5% less repeat investments, than reductions
Existing positions increased: 139 | Existing positions reduced: 147
1.53% less ownership
Funds ownership: 79.04% → 77.51% (-1.5%)
50% less funds holding in top 10
Funds holding in top 10: 12 → 6 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$52.9M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$51.8M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$46.8M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$39.4M |
| 5 |
SCM
Sirios Capital Management
Boston,
Massachusetts
|
+$38.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$137M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$129M |
| 3 |
GC
Greenlight Capital
New York
|
-$55.1M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$48.8M |
| 5 |
State Street
Boston,
Massachusetts
|
-$40.7M |
CC Hedge Fund Activity: Q2 2017 in Review
462 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q2 2017, worth a combined $5.42B — down 3.1% from $5.6B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new CC positions and 61 closed out — a net gain of 9 holders — while 139 added to existing stakes and 147 trimmed.
The largest buyer was Millennium Management, adding an estimated $52.9M. The largest seller was BlackRock, cutting an estimated $137M.
- 462 institutional investors held Chemours (CC) as of Q2 2017, up from 458 in Q1 2017.
- Funds reported $5.42B of Chemours stock for Q2 2017, down 3.1% quarter-over-quarter.
- 70 funds opened new Chemours positions in Q2 2017 and 61 closed out, a net change of +9 holders.
- The largest Chemours buyer in Q2 2017 was Millennium Management, an estimated $52.9M added.
- The largest Chemours seller in Q2 2017 was BlackRock, an estimated $137M sold.
Based on aggregated 13F filings for Q2 2017.